Cantabio Pharmaceuticals Inc. (CTBO)

[subslover]

Cantabio Pharmaceuticals Inc.
Neurodegenerative disease treatment company, Cantabio Pharmaceuticals Inc. (OTCQB: CTBO) has seen shares rise 6.40% in early morning trading on Tuesday, June 14, 2016. Over the past month, Cantabio Pharmaceuticals Inc. (OTCQB: CTBO) has seen average daily volume stand around 61,776 shares and the pharmaceutical company is on track to see share volume expand over its daily average, as nearly 40,000 shares or around $82,000 in dollar volume has already exchanged hands.

The Palo Alto, CA-based company has not seen any new updates hit the news waves, but Cantabio Pharmacetuicals Inc. (OTCQB: CTBO) was subject of a Seeking Alpha post that was published on June 13, 2016. In the article by Stone Fox Capital, the author acknowledges the risks and drawbacks to the company, but says “the small biotech has promising drug candidates in an area of extreme unmet needs and in need of workable solutions,” (Seeking Alpha). Alzheimer’s, dementia, and other neurodegenerative diseases continue to pose major health care issues, as limited treatment options are available.